FORMULATION AND IN-VITRO EVALUATION OF EFAVIRENZ LIQUISOLID COMPACTS

Abstract

Objective: The present research is aimed to enhance the dissolution rate of Efavirenz using liquisolid compact technology.Methods: About 16 different formulations were developed using factorial design with carriers (Neusilin and Fugicalin), binder (PVP K-30) and vehicle (polyethylene glycol 300) as independent variables and aerosil 200 is used as coating material. The In-vitro drug release from the LSC has used a dependent variable. The empirical method by Spireas and Bolton was applied to calculate the amounts of carrier and coating materials and obtained the improved flow characteristics and hardness by changing the proportion of carrier and coating materials.Results: A 23 factorial design is used and developed LSC using Neusilin (LSC-N1 to LSC-N8) and Fugicalin (LSC-F1 to LSC-F8). The physicochemical evaluation of all formulations exhibited well within the specification limits with respect to weight variation, hardness, friability and content uniformity. The In-vitro drug release from these LSC was evaluated in 0.1 N HCl and the optimized formulation (LSC-N8) was compared with pure drug (capsule) and physical mixture (tablet). The release studies proved that the liquisolid tablets results in higher release profile than pure drug and physical mixture due to increase in surface and wetting properties of the drug.Conclusion: LSC technique confirmed the enhanced dissolution rate of Efavirenz, which in turn helps in improving bioavailability. 

Authors and Affiliations

Sai Sruthi R, Shamili Kaparthi, P. R. Sathesh Babu, C. V. S. Subrahmanyam

Keywords

Related Articles

A NEW METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF PARACETAMOL IN PHARMACEUTICAL DOSAGE FORM BY REVERSE PHASE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Objective: An accurate, simple, reproducible and sensitive method for the determination of paracetamol in pharmaceutical dosage form was developed and validated using a reversed-phase C18 column (250 mm X 4.6 mm i. d, 5...

PROTEINACEOUS COMPOUNDS FROM FRAGARIA ANANASSA FRUIT ATTENUATES PARAQUAT INDUCED PARKINSON LIKE LOCOMOTOR AND MITOCHONDRIAL ALTERATIONS IN ZEBRAFISH

Objectives: To assess the Parkinson like locomotor and mitochondrial alterations, associated with the exposure of paraquat (PQ), in vivo preventive effect of proteinaceous compounds extracted from Fragaria ananassa fruit...

ACUTE TOXICITY EVALUATION OF ETHANOLIC EXTRACT OF ARISTOLOCHIA ALBIDA DUCH. LEAVES ON WISTAR RATS LIVER AND KIDNEY FUNCTIONS

Objective: Aristolochia albida Duch is frequently used by alternative medicine to treat some pathologies like hepatitis. Our main objective was to evaluate the acute oral toxicity of the ethanolic extract of this plant.M...

ANTIMICROBIAL RESISTANCE PROFILES OF BACTERIA ISOLATED FROM CHICKEN DROPPINGS IN DAR ES SALAAM

Objective: To determine resistance profiles of bacteria isolated from chicken droppings.Methods: It was a cross-sectional study involving collection of fresh chicken droppings from 100 chickens from 13 localities; follow...

SYNTHESIS OF NOVEL IMIDAZOLE AND FUSED IMIDAZOLE DERIVATIVES AS CYTOTOXIC AND ANTIMICROBIAL AGENTS: MOLECULAR DOCKING AND BIOLOGICAL EVALUATION

Objectives: The objective of this work is to synthesize novel imidazole and fused imidazole derivatives using 5-arylidene-2-hydrazino-3-phenyl imidazolin-4-ones (5a-c) as key intermediate. The structure of the newly synt...

Download PDF file
  • EP ID EP577929
  • DOI -
  • Views 66
  • Downloads 0

How To Cite

Sai Sruthi R, Shamili Kaparthi, P. R. Sathesh Babu, C. V. S. Subrahmanyam (2016). FORMULATION AND IN-VITRO EVALUATION OF EFAVIRENZ LIQUISOLID COMPACTS. International Journal of Pharmacy and Pharmaceutical Sciences, 8(1), 137-143. https://europub.co.uk/articles/-A-577929